Thermo Fisher Scientific acquired Solventum’s purification and filtration business for $4 billion. The new filtration unit will operate within Thermo Fisher’s Life Sciences Solutions segment.
The deal includes Solventum’s bioprocessing filtration, healthcare and industrial filtration, and membrane technologies, according to an Sept. 2 news release from the devicemaker. The company said the purchase strengthens its bioproduction tools and expands its presence in industries that require ultrapure water such as battery and semiconductor manufacturing.
The business is expected to generate about $750 million in revenue in 2025, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.